The proto-oncogene Bcl-2 inhibits cellular toxicity of dopamine: possible implications for Parkinson‘s Disease

Author： Ziv I.  

Publisher： Springer Publishing Company

ISSN： 1360-8185

Source： Apoptosis, Vol.2, Iss.2, 1997-01, pp. : 149-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson’s disease

By Yasuda Toru  

Apoptosis, Vol. 15, Iss. 11, 2010-11 ,pp. : 1312-1321

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Dopamine Agonists on Neuropsychiatric Symptoms of Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-03 ,pp. : 206-209

Karger

Access to resources Recommend Favorite

Cellular pathology of Parkinson’s disease: astrocytes, microglia and inflammation

By Teismann Peter   Schulz Jörg  

Cell and Tissue Research, Vol. 318, Iss. 1, 2004-10 ,pp. : 149-161

Springer Publishing Company

Access to resources Recommend Favorite

Basic Research on Dopamine in Parkinson’s Disease and the Discovery of the Nigrostriatal Dopamine Pathway: The View of an Eyewitness

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 114-117

Karger

Access to resources Recommend Favorite

Plasma F2A Isoprostane Levels in Alzheimer’s and Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 4, Iss. 6, 2007-10 ,pp. : 403-405

Karger

Access to resources Recommend Favorite